PharmaNet Development Group Hosts Phase IV Symposium in London on June 3, 2010
Post-approval studies are essential in characterizing the real-world performance of medical products in terms of safety, effectiveness, economic value and quality of life. During this symposium, industry leaders will join PharmaNet experts to discuss techniques to optimize post-approval research including:
Please contact Andrew Ecob at firstname.lastname@example.org or +1 44 1494 560 426 for more information or to attend the event. Space is limited.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees in 34 counties and 42 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.
-- Strategic Post-Approval Research Planning, Jeff Trotter, Executive Vice President, Phase IV Development, PharmaNet
SOURCE PharmaNet Development Group, Inc.
You May Also Like